A woman in Wuhan was not infected with the new crown, but was overtaken by prescription drugs and was sent to ICU
A woman in Wuhan was not infected with neocrown virus, but she bought it herself and took an overdose of treatment for neocrown pneumonia. She developed symptoms of mental abnormality and arrhythmia and was sent to the ICU (Intensive Care Unit).
On February 25, Huang Haidong, director of the emergency department of Wuhan Puren Hospital, who accepted the patient, told Peng Mei News (www.thepaper.cn) that the patient's overdose was hydroxychloroquine sulfate. It is a "brother drug" of chloroquine phosphate, which is included in the "New Coronavirus Pneumonia Diagnosis and Treatment Program (Trial Version 6)". In clinical trials, hydroxychloroquine sulfate has been shown to have a certain effect on new coronary pneumonia, which may be the reason for the woman's use.
Huang Haidong said, but the woman did not have new coronary pneumonia, and there was no confirmed or suspected new coronary pneumonia at home. However, she purchased hydroxychloroquine sulfate tablets online and took 18 tablets (1.8 g) within 24 hours. She developed symptoms of mental abnormality, recurrent apical torsional tachycardia (a lethal malignant arrhythmia), and was taken to the hospital on February 23. Hospital rescue.
Huang Haidong reminded that both hydroxychloroquine sulfate and chloroquine phosphate are prescription drugs. When taking, you should follow your doctor's advice. At present, the patient is out of danger, but still needs close observation.
Huang Haidong introduced that hydroxychloroquine sulfate is a "brother drug" of chloroquine phosphate and was previously used for the treatment of diseases such as malaria and lupus erythematosus; hydroxychloroquine sulfate has also been proven to be effective in the treatment of new coronary pneumonia in clinical trials, which may be taken by the woman. s reason.
According to the "New Coronary Virus Pneumonia Diagnosis and Treatment Program (Trial Version 6)" released on the official website of the National Health and Medical Commission on February 19, chloroquine phosphate, as one of the drugs for the treatment of new coronary pneumonia, was included in the trial drug with Abidol. The plan mentioned that the adult therapeutic dose of chloroquine phosphate tablets is 500 mg twice daily.
Peng Mei News previously reported that on February 21, the Hubei Provincial Health and Health Committee issued the "Notice on Close Observation of Adverse Reactions in the Use of Chloroquine Phosphate" to the health committees of municipalities, prefectures, and municipalities directly under the Central Government and provincial medical institutions. The notice mentions, "According to the Wuhan Institute of Virology, Chinese Academy of Sciences, the lethal dose of this drug in adults is 2-4 g, and it is acutely fatal. The designated medical institutions have closely observed during the use of this drug, and cases of adverse reactions have occurred. Please report the information to the Provincial Health and Health Committee in a timely manner. "
Huang Haidong said that under the new crown pneumonia epidemic, the people are easy to panic. Before people snapped up drugs such as Shuanghuanglian, this kind of psychological trouble. Everyone should take good care of their families' mental health, communicate and intervene in a timely manner while taking protective measures to avoid over-anxiety and taking medicines too much, which may even lead to their lives in danger.
Surging journalist Zhu Xuan